BNP Paribas Financial Markets
LABD icon

BNP Paribas Financial Markets’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

BNP Paribas Financial Markets’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.78M Buy
750,064
+700,000
+1,398% +$9.42M ﹤0.01% 1990
2026
Q1 		$816K Sell
50,064
-50,000
-50% -$946K ﹤0.01% 3275
2025
Q4 		$2.11M Sell
100,064
-25,706
-20% -$697K ﹤0.01% 2591
2025
Q3 		$5.06M Buy
+125,770
New +$7.29M ﹤0.01% 1971

Other funds holding LABD

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

BNP Paribas Financial Markets's LABD Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Direxion Daily S&P Biotech Bear 3X ETF (LABD) stake by 1,398% in Q2 2026, buying an estimated $9.42M and bringing the position to 750,064 shares worth $5.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1990.

BNP Paribas Financial Markets first reported a position in LABD in Q3 2025 and has held it in 4 quarters since. 21 funds tracked by Wall St. Rank hold LABD as of Q2 2026.

  • BNP Paribas Financial Markets held 750,064 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $5.78M as of Q2 2026.
  • BNP Paribas Financial Markets bought 700,000 Direxion Daily S&P Biotech Bear 3X ETF shares in Q2 2026, an estimated $9.42M.
  • Direxion Daily S&P Biotech Bear 3X ETF made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1990 holding.
  • BNP Paribas Financial Markets first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q3 2025 and has held it in 4 quarters since.
  • 21 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.